```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3092 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 3092

    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 16, 2015

Ms. Maxine Waters of California (for herself, Mr. Smith of New Jersey, 
    Mr. Fattah, Mr. Garamendi, Mrs. Beatty, Mr. Brendan F. Boyle of 
  Pennsylvania, Mr. Brady of Pennsylvania, Ms. Brown of Florida, Ms. 
    Clark of Massachusetts, Ms. Clarke of New York, Mr. Cohen, Mr. 
  Connolly, Mr. Delaney, Mrs. Dingell, Mr. Doggett, Ms. Edwards, Ms. 
Frankel of Florida, Mr. Grijalva, Ms. Hahn, Mr. Hastings, Mr. Higgins, 
 Mr. Israel, Ms. Jackson Lee, Mr. Johnson of Georgia, Mr. Keating, Ms. 
 Kelly of Illinois, Mrs. Lawrence, Ms. Lee, Mr. Lewis, Mr. Lynch, Ms. 
Matsui, Mr. McGovern, Mr. Nadler, Ms. Norton, Mr. Payne, Mr. Polis, Mr. 
  Rangel, Ms. Linda T. Sanchez of California, Ms. Loretta Sanchez of 
California, Ms. Schakowsky, Mr. David Scott of Georgia, Mr. Sires, Mr. 
   Tonko, Mr. Van Hollen, Mrs. Watson Coleman, Mr. Lipinski, and Mr. 
   Peters) introduced the following bill; which was referred to the 
 Committee on Oversight and Government Reform, and in addition to the 
   Committee on Energy and Commerce, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALZHEIMER'S DISEASE RESEARCH SEMIPOSTAL STAMP.

    (a) In General.--In order to afford a convenient way for members of 
the public to contribute to funding for medical research relating to 
Alzheimer's disease, the United States Postal Service shall issue a 
semipostal stamp (referred to in this Act as the ``Alzheimer's Disease 
Research Semipostal Stamp'') in accordance with the provisions of this 
section.
    (b) Terms and Conditions.--
            (1) In general.--The issuance and sale of the Alzheimer's 
        Disease Research Semipostal Stamp shall be governed by the 
        provisions of section 416 of title 39, United States Code, and 
        regulations issued under such section, subject to the 
        requirements of this subsection.
            (2) Duration.--The Alzheimer's Disease Research Semipostal 
        Stamp shall be made available to the public for a period of 6 
        years, beginning no later than 12 months after the date of the 
        enactment of this Act.
            (3) Disposition of proceeds.--All amounts becoming 
        available from the sale of the Alzheimer's Disease Research 
        Semipostal Stamp (as determined under section 416(d) of such 
        title 39) shall be transferred to the National Institutes of 
        Health, for the purpose described in subsection (a), through 
        payments which shall be made at least twice a year.
    (c) Definition.--For purposes of this Act, the term ``semipostal 
stamp'' refers to a stamp described in section 416(a)(1) of title 39, 
United States Code.
                                 <all>
```